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Background: Synaptic plasticity is the neuronal capacity to modify the function and 
structure of dendritic spines (DS) in response to neuromodulators. Sex steroids, particularly 
17β-estradiol (E2) and progesterone (P4), are key regulators in the control of DS formation 
through multiprotein complexes including WAVE1 protein, and are thus fundamental for the 
development of learning and memory. Objectives: The aim of this work was to evaluate the 
molecular switch Cdk5 kinase/PP2A phosphatase in the control of WAVE1 protein 
(phosphorylation/dephosphorylation) and the regulation of WAVE1 and cortactin to the 
Arp2/3 complex, in response to rapid treatments with E2 and P4 in cortical neuronal cells. 
Results: Rapid treatment with E2 and P4 modified neuronal morphology and significantly 
increased the number of DS. This effect was reduced by the use of a Cdk5 inhibitor 
(Roscovitine). In contrast, inhibition of PP2A with PP2A DN construct significantly 
increased DS formation, evidencing the participation of kinase/phosphatase in the regulation 
of WAVE1 in DS formation induced by E2 and P4. Cortactin regulates DS formation via 
Src and PAK1 kinase induced by E2 and P4. Both cortactin and WAVE1 signal to Arp2/3 
complex to synergistically promote actin nucleation. Conclusion: These results suggest that 
E2 and P4 dynamically regulate neuron morphology through non-genomic signaling via 
cortactin/WAVE1-Arp2/3 complex. The control of these proteins is tightly orchestrated by 
phosphorylation, where kinases and phosphatases are essential for actin nucleation and, 
finally, DS formation. This work provides a deeper understanding of the biological actions 


























   
   
   
   
   
   
   




























Pyramidal neurons from cortex and hippocampus, the main brain areas of language and 
memory development, bear thousands of dendritic spines (DS) [1]. DS are microscopic 
protrusions that constitute the main reception point for excitatory synapses in these neurons. 
As a consequence, failures in DS formation lead to improper cognition and abnormal brain 
function [2]. In the last few years, it has been demonstrated that the sex steroid hormones 
17-β-estradiol (E2) and progesterone (P4) act as neuromodulators and control multiple vital 
functions, among them learning and memory [3]. Both hormones can activate signaling 
pathways that ultimately regulate DS formation, contributing to synaptic plasticity [4-7]. 
The lack of E2 and P4 could therefore be harmful for brain functions. Among others, they 
could specifically affect learning, cognition, memory and lead to the progression of 
degenerative diseases, such as Alzheimer’s disease [8-10]. 
 
Actin filaments are the main cytoskeleton component in DS formation that ultimately will 
allow synapse formation [11]. Consequently, DS formation depends on the actin 
cytoskeleton and its regulatory proteins. The Arp2/3 complex plays a main role in the 
formation of branched actin filaments, leading to membrane protrusion and new DS [11]. 
The Arp2/3 complex is controlled by the Wiskott-Aldrich Syndrome Protein family 
member, verprolin-homologous protein 1 (WAVE1), and cortactin proteins, both known as 
nucleation promoter factors (NPFs) [12]. In this scenario, reversible protein phosphorylation 
plays a key role in rapid cellular responses, such as the activation of these actin regulator 
proteins that enhance new DS formation [13, 14]. Recent studies have demonstrated that 
protein phosphatase 2A (PP2A) could dephosphorylate WAVE1, affecting its function and 
consequently impairing the formation of DS [15]. PP2A is one of the major protein 


























   
   
   
   
   
   
   



























structures [16]. Its deregulation has been implicated in many degenerative diseases [17], 
making its study of great interest.  
Cortactin has been proposed to be fundamental for dendritic spine morphogenesis [18]. This 
scaffolding protein is a controller of the actin cytoskeleton. It is able to regulate actin 
nucleation by activating the Arp2/3 complex synergistically with WASP proteins, including 
WAVE1 [19, 20]. 
During our previous work, we have established that E2 and P4 are important cognitive 
neuromodulators that control rapid signaling pathways leading to the phosphorylation of 
WAVE1 by ER-PR/Gαi-Gβ/Src/Rac1/Cdk5 signaling cascades enhancing neuronal spine 
formation [21, 22]. In this study we aimed to evaluate if rapid treatments with E2 and P4 
control the molecular switch Cdk5 kinase/PP2A phosphatase in the regulation of WAVE1 
via phosphorylation/dephosphorylation, key in DS formation. Furthermore, we wished to 
identify the signaling pathway triggered by cortactin that reinforces the signal of WAVE1 
required for Arp2/3 complex activation and strengthen DS formation in cortical neuronal 
cells. Our results increase our understanding of the complex actions of sex steroids on the 
control of brain physiology. They may provide new tools for endocrine therapies of key 



























   
   
   
   
   
   
   



























MATERIALS AND METHODS  
Primary Culture of Rat Embryonic Cortical Neurons 
Primary cultures of cortical neurons were obtained from embryonic day 18 rat fetuses as 
described [23]. This methodology provides a valuable model for investigating synaptic 
plasticity. Cortical cells were dissected with 0.025 % Trypsin-EDTA (Gibco, Thermo Fisher 
Scientific, Inc.) for 10 min at 37°C and then dissociated. Cells were seeded on six well 
culture dishes pre-coated with PEI (polyethyleneimine, 2% in Borate Buffer pH 8.3) at a 
density of 0.5–1 x 105 cells/cm2. Neurons were grown in Neurobasal medium (Invitrogen) 
supplemented with 10 U/ml penicillin, 10 μg/ml streptomycin, 0.5 mM glutamine, 25 μM 
glutamate, and 2% B27 (Invitrogen) and kept in vitro for 10-12 days. These culture 
conditions generate cultures that are > 95% neuronal and ≤ 5% glial [24]. Animal 
maintenance and handling were conducted according to the NIH guide for the Care and Use 
of Laboratory Animals (NIH publication Nº 86-23, revised 1985 and 1991) and the UK 
requirements for ethics of animal experimentation (Animals Scientific Procedures, Act 
1986). All experimental procedures were approved by the Care and Use of Laboratory 
Animals Committee (CICUAL) of the Faculty of Medical Sciences, National University of 
Cuyo (Protocol approval N° 33/2014), Mendoza, Argentina.  
Progesterone, 17β-estradiol and Forskolin (1 µM) were from Sigma-Aldrich; PP2 (Src 
inhibitor, 10µM) and Roscovitine3 (Cdk5 inhibitor, 50µM) were from Calbiochem; FAK 
inhibitor (FAKi, (1 µM), IPA-3 (PAK1 inhibitor, 10µM) and CK-666 (Arp2/3 complex 
inhibitor, 4µM) were from Santa Cruz Biotechnology. ICI 182,780 (100 nM) was obtained 
from Tocris Cookson (Avonmouth, UK). ORG31710 (1 µM) was obtained from Organon 
Akzo Nobel (Oss, The Netherlands). Whenever an inhibitor was used, the compound was 


























   
   
   
   
   
   
   





























Cell lysates were separated by SDS-PAGE in 8-10% gels and transferred into PVDF 
membranes. Antibodies used were: p-FAK (Y397), Arp3 (612135) (BD Transduction 
Laboratories); Actin (C-11), Cdk5 (sc-56278), p-Cdk5 (Tyr15) (sc-12918), PP2A (sc-13601), 
p-PP2A (Tyr307) (sc-112615), p-FAK (Tyr397) (sc-11765-R), paxillin (sc-31010), p-paxillin 
(Tyr118) (sc-365020), p-Rac1 (sc-135641), p-PAK1 (Thr423) (sc-135755), cortactin (sc-
11408), p-cortactin (Tyr466) (sc-101661) (Santa Cruz Biotechnology); p-Src (Tyr418) 
(ab4816) (Abcam); p-Arp2 (Thr237) (orb-155730) (Biorbyt); WAVE1 (SAB4503508), p-
WAVE1 (S397) (W2768) (Sigma-Aldrich, Saint-Louis, MO); Cdk5 (268-283) (Calbiochem, 
La Jolla, CA). Primary and secondary antibodies were incubated with the membranes using 
standard techniques. Immunodetection was accomplished using enhanced 
chemiluminescence and recorded with a quantitative digital imaging system (Chemidoc 
XRS with Image Lab, Bio-Rad, USA). 
 
Cell immunofluorescence 
Neuronal cells were grown on coverslips, pre-treated with PEI or Poly-D-Lysine as 
described above and maintained in Neurobasal medium. Cells were fixed with 4% 
paraformaldehyde for 20 minutes and permeabilized with 0.1% Triton for 5 minutes. 
Blocking was performed with PBS containing 1% bovine serum albumin for 30 min at room 
temperature (RT). Between each step, cells were carefully washed with PBS two times. 
Cells were incubated with antibodies against synaptophysin (1:100, Santa Cruz 
Biotechnology), PSD-95 (sc-32290) (1:100, Santa Cruz Biotechnology) or p-cortactinY466 
(1:50) overnight in a humidified chamber at 4°C, followed by incubation with Alexa 


























   
   
   
   
   
   
   



























antibody at RT for 2 h. Cells were then incubated with Texas Red-phalloidin (Sigma-
Aldrich) for 30 minutes at RT to visualize actin filaments. After washing, the nuclei were 
counterstained with 4'-6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, Saint-Louis, 
MO) and mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, 
CA). Immunofluorescence was visualized using a Nikon Eclipse E200 microscope and 
recorded with a high-resolution DP70 Olympus digital camera. 
 
Dendritic spines quantification 
In order to determine the dendritic spine classification after (10 nM, 20 min) E2 and P4 
treatments, images of immunostained neurons were visualized with a Nikon Eclipse E200 
microscope. Two dendrites of each neuron were chosen at random, and within each dendrite 
a 10 µm extension region was sampled and dendritic spines were counted. For 
morphological classification of spines, three subtypes were considered: 1) mushroom spines 
were those with a wide head and defined neck, 2) thin spines were those with a long and thin 
defined neck but without a head, and 3) stubby spines were small and wider protrusions 




Cortical neuronal cells were washed with ice-cold PBS and lysed with 20mM Tris-HCl (pH 
7.4), 10 mM EDTA, 100 mM NaCl, 1% Igepal, 1 mM Na3VO4, 50 mM NaF, 0.1 mg/L 
PMSF, 0.3 mg/L aprotinin and 0.01% protease inhibitor mixture (Sigma-Aldrich, Saint-
Louis, MO). Immunoprecipitating antibody against Arp3 (BD Transduction Laboratories) in 
500 μl of lysis buffer was then added and incubated for 1 h at 4°C with gentle rocking. 40 µl 


























   
   
   
   
   
   
   



























2 h at 4°C. The mixture was centrifuged at 12,000 x g for 5 min at 4°C. The supernatant was 
removed and the immunoprecipitates washed with 500 ml of 20 mM Tris-HCl (pH 7.4), 10 
mM EDTA, 150 mM NaCl, 1% IGEPAL, 1 mM Na3VO4, 50 mM NaF, 0.1 mg/L PMSF, 0.3 
mg/L aprotinin and 0.01% protease inhibitor mixture (Sigma-Aldrich, Saint-Louis, MO). 
Immunoprecipitated proteins were separated under reducing and denaturing conditions by 
10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane. Non-specific 
binding was blocked with 3% BSA (Bovine serum albumin) in PBS–Tween 20. Membranes 
were incubated with anti-cortactin and Arp3 antibodies. 
 
Gene silencing with RNA interference 
Synthetic small interfering RNAs targeting WAVE-1 (siRNA SMARTpool WAVE-1) and 
control siRNAs (D-001810-01-05) were purchased from Dharmacon (Thermo Fisher 
Scientific Inc). Paxillin siRNAs and control siRNAs were purchased from Santa Cruz 
Biotechnology (Santa Cruz Biotechnology). The siRNAs were used at a final concentration 
of 50-75 nM. Cortical neurons were treated 48 h after siRNAs transfection. Efficacy of gene 
silencing was checked with Western analysis and found to be optimal at 48 h. 
 
 
Transfection experiments  
A mutant construct for cortactin (cortactin3YF, a mutant form of cortactin with Tyr changed 
to Phe, which prevents cortactin phosphorylated in Y421/466/482 by Src) was generously 
provided by Dr. John Cooper (Washington University School of Medicine, USA). The insert 
was cloned in a pcDNA 2AB Flag-cortactin 3YF [26]. A phosphorylation mimic mutant of 
PP2A (PP2AY307E) and a non-phosphorylatable mutant of PP2A (PP2AY307F) were a kind gift 
from Dr. David C. Pallas (Winship Cancer Institute, Emory University School of Medicine, 


























   
   
   
   
   
   
   



























cDNA Resource Center (www.cdna.org). The inserts were cloned in pcDNA3.1+. The 
plasmids (10 μg) were transfected into cortical neurons using Lipofectamine (Invitrogen, 
Carlsbad, CA). Parallel cells were transfected with empty pcDNA3.1+ plasmid. Cells (60–
70% confluent) were treated 24-48 h after transfection. 
 
Statistical analysis  
All values are expressed as (mean ± SD) of three independent experiments. Statistical 
analysis of the data was performed using one-way analysis of variance (ANOVA) followed 
by Dunnett’s multiple comparisons test with GraphPad Prism 5 software. P<0.05 was 


























   
   
   
   
   
   
   




























Rapid treatments with E2 and P4 increase thin dendritic spine formation 
We have previously reported that treatments with 17β-estradiol (E2) and progesterone (P4) 
act as potent neuromodulators of cortical neuronal dendritic architecture [21, 22]. To 
continue investigating the molecular mechanisms that regulate the control of DS formation, 
we evaluated the rapid action of E2 (10 nM) and P4 (10 nM) on cortical neuronal cells (Fig. 
1A-C). By immunofluorescence, we observed that E2 and P4 exposure for 20 min rapidly 
modifies neuron morphology, significantly increasing DS density compared to control cells 
(Fig. 1A-B). To further investigate the morphological classification of spines induced by E2 
and P4 in cortical neuronal cells, we quantified three typical DS morphologies, mushroom, 
stubby and thin, in cells treated with E2 (10 nM, 20 min) and P4 (10 nM, 20 min). This 
treatment significantly increased the number of thin spines compared to control conditions 
(Fig. 1C). Thin spines are first formed during spinogenesis. They are able to become into 
mature spines by acquiring a mushroom morphology during synaptic plasticity processes 
[27]. These results suggest that E2 and P4 promote the rapid development of thin spines, 
modulating the early rearrangement of DS structure and contributing to synaptic plasticity 
processes.  
To evaluate whether E2 and P4 increase synapse formation and the implications of rapid and 
transient nature of the structural changes induced by E2 and P4, we used the pre- and post-
synaptic markers synaptophysin and PSD-95, respectively (Figure 1D-I). We observed that 
exposure to E2 and P4 during 20 min significantly increased the density of synaptophysin 
(Figure 1D-F) and PSD-95 (Figure 1E-G), as well as the number of dendritic spines 



























   
   
   
   
   
   
   



























Estrogen and progesterone modulate DS formation through Src/FAK/paxillin/Rac1 in 
neuronal cells  
We have previously demonstrated that Src and focal adhesion kinases (FAK) are 
fundamental in the signaling cascade and responsible for enhancing neuronal dendritic spine 
formation via WAVE1 [21, 22]. Other authors have described that both proteins recruit 
paxillin, a structural cytoskeleton component necessary for dendritic spine morphogenesis 
[28]. For this reason, we wanted to evaluate if these proteins are involved in the previously 
described signaling pathway. The Src kinase inhibitor (PP2, 10 μM) and the specific FAK 
inhibitor (FAKi, 1 μM) blocked FAKY397 and paxillinY118 phosphorylation induced by E2 
and P4 (Fig. 2A-C).  
In order to clarify whether Rac1 GTPase could mediate the signaling of E2 and P4 to 
WAVE1 and cortactin, we blocked paxillin with small interfering RNAs and Rac1 with 
dominant negative constructs. Paxillin silencing impaired both paxillinY118 and Rac1S71 
phosphorylation in the presence of E2 and P4 (Fig. 2D-F). Blockade of Rac1, however, 
impaired Rac1 phosphorylation by E2 or P4, but not of paxillin (Fig. 2D-F), supporting the 
concept that E2 and P4 signal to Src/FAK/paxillin/Rac1 cascade leading to DS formation. 
As control, we observed that paxillin expression was significantly reduced when cortical 
neuronal cells were transfected for 24 h with paxillin siRNA (Fig. 2G-H), whereas cells 
transfected with the dominant negative mutant of Rac1 showed increased Rac1 expression 
(Fig. 2I-J).  
By immunofluorescence we visualized that the inhibition of Src (PP2), FAK (FAKi) and 
paxillin (siRNAs) abolished the increase in spine density triggered by the treatment with E2 



























   
   
   
   
   
   
   



























E2 and P4 induce DS formation via WAVE1 through the molecular switch Cdk5 
kinase/PP2A phosphatase 
We have previously shown that estrogen and progesterone trigger a rapid phosphorylation of 
Cdk5 through Rac1 GTPases and promote the formation of DS in rat cortical neurons [21, 
22]. Ceglia et al. have demonstrated that the molecular switch Cdk5 kinase/PP2A 
phosphatase controls WAVE1 phosphorylation and, consequently, DS formation [15], but 
the action of E2 and P4 on this switch remains to be elucidated. Hence, our next step was to 
evaluate this molecular control. We observed a significant increase in Cdk5Y15 and 
WAVE1S397 phosphorylation during 20 min of E2 and P4 exposure (Fig. 3A-C). Treatment 
of neuronal cells with the specific Cdk5 inhibitor Roscovitine resulted in a clear inhibition 
of Cdk5Y15 and WAVE1S397 phosphorylation during exposure to E2 and P4 (Figure 3A-C).  
The increase in DS density after treatment with E2 and P4 (Fig. 3D-E) was completely 
prevented with Roscovitine (Fig. 3D-E). This result suggests that E2 and P4 induce WAVE1 
phosphorylation and lead to DS formation through Cdk5 kinase.  
According to studies performed by Chen Jian and collaborators, phosphatase PP2A activity 
is regulated by tyrosine phosphorylation on residue 307 [29]. We therefore analyzed the 
effect of E2 and P4 on phosphorylation levels of PP2A and WAVE1 and, consequently, DS 
formation. We observed that both hormones significantly increase the inhibitory 
phosphorylation levels of PP2AY307 (Figure 3F-G), in parallel with WAVE1S397 
phosphorylation (Figure 3F and H). Treatments with the PP2A activator Forskolin, 
significantly reduce the inhibitory phosphorylation levels of PP2AY307 and WAVE1S397 
(Figure 3F-H) and significantly abolish the increase of DS induced by E2 and P4 (Figure 3I-
J). These results suggest that E2 and P4 regulate PP2A activity by increasing PP2AY307 


























   
   
   
   
   
   
   



























phosphorylation and promotes DS formation. Reducing PP2AY307 phosphorylation with 
Forskolin results in WAVE1 dephosphorylation and a reduction in DS formation triggered 
by E2 and P4.  
 
PP2A phosphatase regulates WAVE1 and DS formation induced by estrogen and 
progesterone  
In the figure 3, we have shown that PP2A is an important component of the regulation 
mechanism of WAVE1 and, consequently, of the formation of DS induced by E2 and P4. As 
a next step, we aimed to investigate whether the inhibitory phosphorylation of PP2A (Tyr307) 
could be responsible for the dephosphorylation of WAVE1 and DS formation. We 
transfected cortical neurons with two mutant constructs of PP2A, PP2AY307E that mimics a 
constitutive phosphorylation in the C subunit of PP2A and therefore acts as dominant 
negative (DN) construct, and PP2AY307F that cannot become phosphorylated and thus acts as 
a constitutively active (CA) form of the protein. The transfections with both plasmids 
increased the expression of the catalytic subunit of PP2A that contains the specific residue 
(Tyr307) (Figure 4A-B). In addition, the transfections with PP2AY307E resulted in an increase 
in WAVE1S397 phosphorylation (Figure 4A-C) and DS density (Figure 4D-E), while the use 
of the CA construct impaired these effects (Figure 4A,C and D-E), suggesting a specific role 
of PP2AY307 in the control of WAVE1 and DS formation induced by E2 and P4.  
Phosphatase PP2A interacts with Src kinase, leading to its inactivation [30, 31]. We 
therefore evaluated whether Src is involved in the control of PP2A phosphorylation by using 
the specific Src inhibitor (PP2). We demonstrated that E2 and P4 induced SrcY418 and 
PP2AY307 phosphorylation. This effect was prevented by PP2, suggesting a crucial role of 


























   
   
   
   
   
   
   



























completely abolished E2 and P4-dependent cortactinY466 phosphorylation (Fig. 4F and I), 
suggesting that Src acts as a central protein between PP2A and cortactin, modulating the 
signal that promote the DS formation in cortical neurons. 
 
Cortactin participates in the E2 and P4 signaling to the formation of dendritic spines 
via Src and Rac1/PAK1 in cortical neurons 
Previous studies have provided evidence that paxillin signals to PAK1 serine/threonine 
kinase, an effector of Rac1 GTPases. When PAK1 is phosphorylated, it may allow the 
recruitment of cortactin to promote the development of protrusive membrane structures [32, 
33], a mechanistic process that shares similarities with DS formation [34]. Cortactin is 
regulated by several proteins like Src and PAK1 that modulate its function via specific 
phosphorylations [35]. Src tyrosine kinase targets tyrosine residues Y421/466/482, while PAK1 
phosphorylates serine S113 [36, 37]. We demonstrated that in Rac1-transfected cells, 
phosphorylation of Rac1S71 and PAK1T423 was significantly lower after E2 and P4 treatment, 
whereas the inhibition of PAK1 with the specific inhibitor IPA-3 lead to a decrease in 
PAK1T423 phosphorylation but did not affect the Rac1S71 phosphorylation in cortical 
neuronal cells (Fig. 5A and C), suggesting that E2 and P4 signal to Rac1 and PAK1 to 
finally promote cortactin phosphorylation. 
Cortactin has been previously described to be concentrated in dendritic spine [18, 38]. We 
therefore evaluated the distribution of phosphorylated cortactinY466 in dendritic protrusions 
of cortical neurons after treatment with E2 and P4. In control cells, phospho-cortactinY466 
was diffusely distributed throughout the dendrites (Fig. 5D). Treatment for 20 min with E2 
and P4 induced an increase in phospho-cortactinY466 levels and its translocation to the edge 


























   
   
   
   
   
   
   



























phospho-cortactinY466 was impaired by the blockade of cells expressing a cortactin mutant 
that prevents cortactin phosphorylation in the residue Y466 (cortactin3YF) (Figure 5D-E), 
induced by Src (Fig. 4F and I).  
To test the specific role of Rac1, PAK1 and cortactin on the control of DS formation, we 
performed immunofluorescence assay (Figure 5F-G). The increase in DS formation induced 
by E2 and P4 was abolished after the blockade of Rac1 (Rac1T17N), PAK1 (IPA-3) and the 
transfection of a non-phosphorylatable construct of cortactin (cortactin3YF) in neuron cells 
(Figure 5F-G), suggesting that Src and Rac1/PAK1 are fundamental in the cortactin 
function, via specific phosphorylations, modulating the control of DS formation triggered by 
E2 and P4 (Fig. 5A-G and Fig. 4F and I). These results highlight the important role of 
cortactin as a key component in the control of DS formation regulated by E2 and P4 in 
neuronal cells. 
 
Estrogen and progesterone control Arp2/3 complex through cortactin-dependent 
signaling pathway 
Previous studies have indicated that cortactin interacts with the Arp2/3 complex by binding 
to Arp3 subunit in vitro [39]. We used immunoprecipitation assays to test the interaction 
between Arp3 subunit and cortactin protein after treatment with E2 and P4. Both hormones 
reduced the interaction of cortactin with Arp3 subunit compared to control treatments 
(Figure 6A-D).  
To explain this dissociation we tested whether the pulse with E2 (20 min) and P4 (20 min) 
could lead to phosphorylation of Arp2 subunit (Arp2/3 complex) and dissociation from 
cortactin by increasing phosphorylation levels of Arp2, since it has been previously 


























   
   
   
   
   
   
   



























phosphorylation seems to be fundamental for binding the pointed end of actin filaments and 
promote the actin nucleation process [41]. We show here that E2 and P4 significantly 
increase Arp2T237 phosphorylation (Figure 6E-H) and that this effect is prevented by 
transfection of the cortactin construct (cortactin3YF) (Figure 6E-H), suggesting that E2 and 
P4 promote Arp2T237 phosphorylation and the consequent dissociation of cortactin from the 
Arp2/3 complex.  
  
Regulation of Arp2/3 complex by cortactin and WAVE1 in neuron cells 
Actin nucleation by the Arp2/3 complex is fundamental for the rapid formation of an actin 
network at the leading edge of the cell [42]. Arp2/3-complex is regulated by upstream NPFs, 
including cortactin and WAVE1 [12, 43]. We studied whether the phosphorylation of 
cortactin and WAVE1 induced by estrogen and progesterone may specifically regulate 
Arp2/3 complex in neuronal cells. Rapid treatment with E2 (20 min) and P4 (20 min) 
significantly increased the phosphorylation levels of cortactinY466 (Figure 7A and C), 
WAVE1S397 (Figure 7A and D) and Arp2T237 (Figure 7A and E). The transfection with 
cortactin3YF (Figure 7A-B) impaired the phosphorylation of cortactinY466 (Figure 7A and C) 
and Arp2T237 (Figure 7A and E), but did not affect the WAVE1S397 phosphorylation induced 
by E2 and P4 (Figure 7A and D).  
In parallel, silencing of WAVE1 with specific siRNAs significantly decreased WAVE1S397 
(Figure 7F and H) and Arp2T237 (Figure 7F and J) phosphorylation induced by both 
hormones, whereas the cortactinY466 phosphorylation was not modified (Figure 7F-I).  
 
Estrogen and progesterone induce the formation of dendritic spines via ER/PR to 


























   
   
   
   
   
   
   



























Phosphorylation of Arp2 in Threonine237 residue is a key regulatory step for Arp2/3 complex 
mediated nucleation [41]. We used a specific inhibitor of the Arp2/3 complex (CK-666) to 
evaluate the specific role of Arp2/3 complex in cortical neurons (Figure 8A-D). Treatment 
with CK-666 significantly impaired Arp2T237 phosphorylation (Figure 8A-B) and DS 
formation (Figure 8C-D) during E2 and P4 administration.  
Finally, to confirm that the specific phosphorylation of PP2A, WAVE1 and Arp2/3 complex 
occurs through estrogen (ER) and progesterone receptors (PR), we used the specific ER/PR 
antagonists ICI 182,780 (100 nM) and ORG 31710 (1 µM), respectively. Blockade of ER 
and PR completely abolished E2 and P4-dependent PP2A, WAVE1 and Arp2/3 


























   
   
   
   
   
   
   




























The study of dendritic spine (DS) formation has gained interest in the past few years, 
especially due to the important role of these structures in establishing excitatory neuronal 
circuits for memory acquisition and enabling learning and cognition [44]. Neurons from 
cognitive brain regions like cortex and hippocampus depend on the neuronal plasticity to 
remodel their connections [45], thorough dynamic actin cytoskeleton polymerization/de-
polymerization and the development of protrusive membrane structures, such as DS [22]. 
The sex steroids estrogen and progesterone modify DS density, regulating neuron 
morphology [4], synaptic plasticity [5] via actin cytoskeleton reorganization, developing DS 
[21, 22]. Dendritic spine density in pyramidal neurons of the cortex correlates with 
circulating estradiol levels [8]. E2 and P4 exert morphological changes in dendrites and 
synapses, and even modify neurotransmitter levels during periods of marked fluctuations in 
their levels, such as puberty, reproductive cycles, pregnancy or menopause, [4]. These 
events depend on the rapid regulation of several proteins that control the actin 
polymerization/de-polymerization, leading to the formation of new DS. 
The major findings of this work is that we demonstrate that E2 and P4 signal to the actin 
controllers cortactin/WAVE1-Arp2/3 complex and trigger a rapid modification of cell 
membrane morphology, promoting DS formation and enhancing neuronal plasticity. These 
events are mediated through two main rapid signaling pathways. One of them is triggered by 
E2 and P4 to ER-PR/Src/FAK/paxillin. When paxillin is phosphorylated, it recruits Rac1 
and Cdk5, leading to WAVE1S397 phosphorylation and enhancing DS formation. In the other 
pathway, E2 and P4 recruit an ER-PR/Src/FAK/paxillin/Rac1/PAK1/cortactin cascade, 
which leads to cortactin phosphorylation and redistribution to sites where DS are formed. In 
addition, we provide evidence that Rac1 GTPase is a central protein that controls actin 


























   
   
   
   
   
   
   



























We also observed that E2 and P4 increase the number of thin DS within minutes of 
treatment, while the quantity of mushroom and stubby shapes remains without changes. 
Thin DS are highly dynamic and can retract and expand within hours of being stimulated 
[46]. They are considered a transient phenotype and a good substrate to become a mature 
spine after increased synaptic inputs [46, 47]. Here, we also demonstrated that E2 and P4 
increase the density and localization of pre- and post-synaptic markers (synaptophysin and 
PSD-95, respectively) in DS, suggesting that the hormones may stimulate synaptogenesis in 
cortical neuronal cells. These changes driven by sex hormones involve the formation of DS 
and their maturation from thin spines to a mushroom phenotype as well as synaptogenesis, 
which is a crucial aspect of cognitive development [48]. 
In previous studies we found that E2 and P4, via Estrogen and/or Progesterone Receptors 
(ER/PR), represent the starting platform to phosphorylate/activate Src and FAK, leading to 
an increased DS formation in neurons via the small G proteins Gαi1 and Gβ1 [21, 22]. Here, 
we continued evaluating the rapid actions of E2 and P4 on diverse kinases and scaffold 
proteins involved in cell morphology and movement. 
Additionally, this study shows that E2 and P4 increase the phosphorylation levels of p-
Rac1S71 by regulating the actin cytoskeleton through Src, FAK and paxillin proteins. Rac1 
GTPases represent key regulators of actin dynamics. Active Rac1 promotes F-actin 
polymerization, which leads to axon outgrowth and extension as well as dendritic spine 
formation through the activation of downstream effectors, such as Cdk5 and PAK1 [2]. We 
confirm that the phosphorylation of Rac1S71 is essential for Cdk5 activation, leading to 
WAVE1 phosphorylation and increasing DS formation after rapid treatments with E2 and 
P4. Roscovitine, Cdk5 inhibitor, abrogated this event and this is in agreement with our 


























   
   
   
   
   
   
   



























We describe for the first time that E2 and P4 control WAVE1 phosphorylation by the 
molecular switch Cdk5 kinase/PP2A phosphatase. PP2A is a major phosphatase with 
important implications for human health. Deficiencies in its activity have severe health 
consequences as a result of an unbalanced phosphorylation status [49]. Both, the down-
regulation and an increased phosphorylation of PP2AY307 are correlated with hyper-
phosphorylation of Tau protein in Alzheimer disease [50]. Here we show that E2 and P4 via 
ER/PR increase PP2AY307 phosphorylation that leads to an enhanced WAVE1 
phosphorylation and DS formation. Reducing PP2AY307 phosphorylation with the specific 
PP2A activator Forskolin causes WAVE1 dephosphorylation and therefore reduces DS 
formation. The expression of PP2A DN and CA mutants further confirms that the 
phosphorylation of PP2AY307 is necessary for DS formation mediated by these hormones. 
Only a few other research groups have addressed the role of PP2A in DS formation. Li et al. 
recently indicated that PP2A is necessary for DS formation in striatal neurons [51, 52]. Liu 
et al. determined that PP2A interacts with the protein PRG-1 at the postsynaptic density not 
only to modulate synaptic plasticity, but also to produce the recruitment of focal adhesion 
proteins like Src and paxillin [53]. Here, we determined that E2 and P4 reduce PP2A activity 
via Src kinase, leading to an increase in WAVE1 phosphorylation and, hence, DS formation 
(Figure 9). This is supported by several studies that link PP2A with Src kinase family [30, 
31]. 
Cortactin is another key NPF enriched in spines and involved in the regulation of DS 
morphology. A decrease in its expression reduces DS density, whereas its overexpression 
enhances spine length [18]. Here we propose that E2 and P4 increase cortactin 
phosphorylation and redistribution near the dendritic protrusions through two pathways, via 
Src/FAK/paxillin/Rac1/PAK1 and/or directly through Src kinase (Figure 9). PAK1 


























   
   
   
   
   
   
   



























phosphorylates cortactin in Tyr 421, 466 and 482 [36, 37]. Furthermore, we describe that 
cortactin interacts with Arp3 subunit, and that E2 or P4 disrupts this interaction. We also 
observed that both hormones increase Arp2T237 subunit phosphorylation. We confirmed that 
Arp2 phosphorylation disrupt the interaction between Arp3 and cortactin and thus stabilize 
the new F-actin branches. Cortactin and WAVE1 interact with the Arp2/3 complex, and both 
independently regulate actin nucleation [20]. The latter is based on two observations: first, 
when cortactin phosphorylation is impaired, phosphorylation of Arp2, but not WAVE1, is 
reduced. Second, the impairment of WAVE1 phosphorylation leads to a reduction in 
phosphorylation of Arp2, but not of cortactin.  
Several works have shown that WAVE1 knockout mice exhibit reduced memory and 
learning [54], and loss of WAVE1 function in vivo or in cultured neurons results in a 
reduction in the number of mature dendritic spines [22]. Whereas a reduced cortactin 
expression has been found in brain tissue from postmortem patients with schizophrenia [55]. 
On the other hand, loss of Arp2/3 activity in excitatory cortical neurons leads to an 
asymmetric structural plasticity of DS resulting in a progressive loss of DS spine synapses 
[56]. Altogether, this evidence suggests that dysfunctions in actin signaling that converge in 
Arp2/3-mediated nucleation may explain the etiology of neurodegenerative disorders 
affecting cognition when a loss of estrogens and progestins occurs.   
In conclusion, our results highlight that E2 and P4 rapidly exert a tight regulation on Arp2/3 
complex activation, orchestrating different branches of  signaling pathways that culminate 
with the phosphorylation of cortactin, WAVE1, and finally Arp2 in order to enhance DS 
formation in cortical neurons, and thus regulate synaptic plasticity (Figure 9) [21, 22, 41]. 
Our results are particularly important for women receiving estrogen replacement, as they 
could potentially prevent or even reverse the age-related decline in learning and memory 


























   
   
   
   
   
   
   



























manipulation with a view to future therapy that could help to engineer newer and more 
selective pharmacologic tools for endocrine therapies against some of the gender-related 


























   
   
   
   
   
   
   



























FIGURE LEGENDS  
Figure 1. 17-β-estradiol (E2) and progesterone (P4) enhance dendritic spine density. A) 
Cortical neurons were cultured and treated with E2 and P4 (10 nM, 20 min), actin filaments 
were counterstained with Texas Red-phalloidin and cell nuclei with DAPI. Representative 
photographs of cortical neuronal cells are shown with immunofluorescence (scale bar = 10 
µm). The inserts show dendritic spines at higher magnification from the white boxes (scale 
bar = 5 μm). The results are derived from the sampling of five areas of the cell membrane of 
30 randomly chosen cells. B) Mean ± SD of the number of spines in 10 µm of dendrite 
length (20-30 neurons from three independent experiments were analyzed per condition). 
*p˂0.05 vs. control, CON. C) Number of the three typical morphologies of DS, mushroom, 
stubby and thin, after hormone stimulation (20-30 neurons from three independent 
experiments). *p˂0.05 vs. CON. D-E) Representative image of dendritic spines (Texas Red-
phalloidin) co-stained for synaptophysin (Alexa Fluor™488) and for PSD-95 (Alexa 
Fluor™350) markers. F-G) Mean ± SD of synaptophysin and PSD-95 density vs. CON. H-
I) Quantitative analysis of the number of overall synaptophysin and PSD-95 puncta 
(synaptophysin and PSD-95 puncta per 10 μm dendrite length) containing spines (n= 25 
cells per condition). *p˂0.05 vs. CON. The experiments were repeated three times with 
consistent results. The scale bar corresponds to 10 μm.  
 
Figure 2. E2 and P4 promote dendritic spine formation via Src/FAK/paxillin/Rac1.  
Cortical neurons were treated with the specific inhibitor of Src (PP2, 10 µM) and FAK 
kinase (FAKi, 1 µM) for 45-60 min before E2 and P4 treatments (10 nM, 20 min). A) 
Expression of phosphorylated FAKY397 and paxillinY118 were analyzed with Western blot 


























   
   
   
   
   
   
   



























Intensity values of each phosphorylated protein were adjusted to actin intensity and 
normalized to the control. *p˂0.05 vs. control, CON. D-G-I) Neurons were transfected with 
specific siRNAs vs. paxillin (siRNA paxillin) and with a Rac1 dominant negative mutant 
(Rac1DN) for 48 h before hormone treatments. Paxillin, p-paxillinY118, Rac1 and p-Rac1S71 
were assayed with Western analysis. E-F) Phospho-paxillinY118, p-Rac1S71 and H-J) 
Paxillin, Rac1 densitometry values were adjusted to actin intensity and normalized to the 
control. *p˂0.05 vs. control, CON. K) Dendritic spine density was measured with 
immunofluorescence after staining actin fibers with Texas Red-phalloidin. The scale bar 
corresponds to 5 μm. L) Quantitative analysis of spine density expressed as the number of 
spines per 10 μm dendrite length (20-30 neurons from three independent experiments were 
analyzed per condition). Results are expressed as the mean ± S.D. *p<0.05 vs. CON. The 
experiments were performed in triplicates and representative images are shown.  
 
Figure 3. Molecular switch Cdk5/PP2A regulates WAVE1 and DS formation. Neuron 
cells were exposed for 20 min to E2 (10 nM) and P4 (10 nM) in the presence or absence of 
the Cdk5 inhibitor (Roscovitine, 50 µM). A) Cdk5, p-Cdk5Y15, WAVE1 and p-WAVE1S397 
were assayed with Western analysis. Phospho-Cdk5Y15 and p-WAVE1S397 densitometry 
values were adjusted to Cdk5 and WAVE1 intensity and normalized to the control. CON, 
Control. B-C) Optical densitometry was performed in triplicate with consistent results; 
representative images are shown. *p˂0.05 vs. CON. D) Dendritic spine formation and 
number were measured with immunofluorescence after staining actin fibers with Texas Red-
phalloidin. The scale bar corresponds to 5 µm. E) Quantitative analysis of spine density 
expressed as the number of spines per 10 µm dendrite length. The results are expressed as 
the mean ± S.D. *p˂0.05 vs. CON. F) Cortical neurons were treated with PP2A activator 


























   
   
   
   
   
   
   



























phosphorylated PP2AY307 and WAVE1S397 was analyzed with Western blot. G) 
Densitometric analysis of phospho-PP2AY307 and phospho-WAVE1S397 bands. Intensity 
values of each phosphorylated protein were adjusted to the corresponding PP2A and 
WAVE1 intensity values and then normalized to the control. *p˂0.05 vs. CON. I) Dendritic 
spine density analysis. Cells were counterstained with Texas Red phalloidin to visualize 
actin filaments. The scale bar corresponds to 5 µm. The graph shows the mean value ±SD of 
the number of spines in 10 µm of dendrite length (20-30 neurons from three independent 
experiments were analyzed per condition). *p˂0.05 vs. CON.  
 
Figure 4. Expression of PP2A mutant constructs affects DS formation. The mutant 
constructs of PP2A (PP2AY307E and PP2AY307F) were transfected into cortical neuronal cells 
and incubated in the presence of E2 and P4 (10 nM) for 20 min. A) Actin, phospho-
WAVE1S397 and PP2A were assayed in cell extracts. B-C) The densitometry values were 
adjusted to actin intensity, then normalized to the control sample. *p˂0.05 vs. corresponding 
control. D-E) Analysis of dendritic spine density. Note that in the PP2A DN group, E2 and 
P4 PP2A DN increased the number of DS, although the difference was not statistically 
significant. Cells were counterstained with Texas Red phalloidin to visualize actin filaments. 
The scale bar corresponds to 5 µm. The graph shows the mean value ± SD of the number of 
spines in 10 µm of dendrite length (20-30 neurons). CON, Control. F) Cells were exposed to 
E2 and P4 for 20 min in the presence or absence of PP2 (10 μM), and Src, PP2A and 
cortactin phosphorylation were analyzed through Western blot assay. G-I) Phospho-SrcY418 
p-PP2AY307 and cortactinY466 densitometry values were adjusted to actin intensity and 
normalized to the control. All experiments were performed in triplicate with consistent 


























   
   
   
   
   
   
   




























Figure 5. E2 and P4 mediated cortactin phosphorylation and redistribution via 
Rac1/PAK1 in rat cortical neurons. Neuron cells were treated with E2 (10 nM) and P4 (10 
nM) for 20 min in the presence or absence of IPA-3 for 45 min (0,5 µM) and transfected 
with Rac1DN and cortactin3YF mutant constructs. A) Expression of phosphorylated Rac1S71 
and PAK1T423 was analyzed with Western blot. B-C) Densitometric analysis of p-Rac1S71 
and p-PAK1T423 bands. Intensity values of each protein were adjusted to the corresponding 
intensity values of actin and then normalized to the control sample. *p˂0.05 vs. control, 
CON. D) Quantification of the cell membrane dendrite-localized phospho-cortactinY466 in 
the different conditions. E) Mean ± SD of the pixel intensity of phospho-cortactinY466 vs. 
CON. *p˂0.05 vs. CON. Dendrite-localized phospho-cortactinY466 was counted in 30 
different cells. F) Dendritic spine density was measured with immunofluorescence after 
staining actin fibers with phalloidin/Texas Red. The scale bar corresponds to 5 μm. G) 
Quantitative analysis of spine density expressed as the number of spines per 10 μm dendrite 
length. *p˂0.05 vs. CON. The experiments were repeated three times with consistent results.  
 
Figure 6. E2 and P4 may modulate the molecular interaction between cortactin and 
Arp2/3 complex in cortical neuronal cells. Neurons were treated with A-B) E2 (10 nM) or 
C-D) P4 (10 nM), both for 20 min, and the cell protein extracts immunoprecipitated (IPs) 
with an antibody vs. Arp3. IPs were assayed for co-immunoprecipitation of cortactin and 
Arp3. Membranes were re-blotted for the immunoprecipitated protein to show equal loading. 
E-H) Cells were treated for 20 min with (E-F) E2 (10 nM) or (G-H) P4 (10 nM) after 


























   
   
   
   
   
   
   



























were analyzed in the cell protein extracts. *p˂0.05 vs. CON. The experiments were 
performed in triplicate; representative images are shown. CON, Control. 
 
Figure 7. Cortactin and WAVE1 control DS formation through the regulation of 
Arp2/3 complex. A) Cortical neurons were treated with E2 (10 nM) and P4 (10 nM) for 20 
min in the presence or absence of cortactin3YF plasmid. Total cell amount of wild-type 
cortactin, p-cortactinY466, p-WAVE1S397, p-Arp2T237 and actin are shown with Western blot. 
B-E) Phospho-cortactinY466, p-WAVE1S397 and p-Arp2T237 densitometry values were 
adjusted to actin intensity, respectively, then normalized to the control sample. F-J) Cortical 
cells were transfected with siRNAs vs. WAVE1, and protein analysis for WAVE1, p-
WAVE1S397, p-cortactinY466, p-Arp2T237 and actin was performed on cell lysates after 
treatment for 20 min with E2 and P4 (both 10 nM). Phospho-WAVE1S397, p-cortactinY466 
and p-Arp2T237 densitometry values were adjusted to actin intensity, then normalized to the 
control sample. *p˂0.05 vs. corresponding control. 
 
Figure 8. Arp2/3 complex is involved in the final step to promote DS formation induced 
by E2 and P4.  Cortical cells were exposed for 20 min to E2 (10 nM) and P4 (10 nM) in the 
presence or absence of the Arp 2/3 complex inhibitor CK-666 (4 µM). A) Actin and 
phospho-Arp2T237 were analyzed through Western blot assay. B) Phospho-Arp2T237 
densitometry value was adjusted to actin intensity, then normalized to the control sample. 
CON, Control. All experiments were performed three times and representative blots are 
presented. *p˂0.05 vs. CON. C) Dendritic spine density analysis. Cells were counterstained 
with Texas Red-phalloidin to visualize actin filaments. The scale bar corresponds to 5 µm. 


























   
   
   
   
   
   
   



























three independent experiments per condition. *p˂0.05 vs. CON. E) Cortical neurons were 
exposed for 20 min to E2 and P4 in the presence or absence of the ER/PR antagonists ICI 
182,780 and ORG 31710. Phosphorylation of PP2A, WAVE1 and Arp2 were assayed with 
Western analysis. F) Densitometric analysis of p-PP2A1Y307, p-WAVE1S397 and p-Arp2T237 
bands. Intensity values of each protein were adjusted to the corresponding intensity values of 
actin and then normalized to the control sample. *p˂0.05 vs. CON. 
 
Figure 9. Representative intracellular signaling of E2 and P4 to cortactin/WAVE1-
Arp2/3 complex implicated in the control of DS formation. Novel mechanism triggered 
by E2 and P4 regulates actin nucleation via cortactin and WAVE1 and their target protein 
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